Accessibility Menu
NovAccess Global logo

NovAccess Global

(OTC) XSNX

Current Price$0.00
Market Cap$6.20K
Since IPO (1998)-100%
5 Year-100%
1 Year+0%
1 Month+0%

NovAccess Global Financials at a Glance

Market Cap

$6.20K

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.89M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-8.22 (Low)

Price

$0.00

Volume

170

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

Oct 29, 2025

XSNX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NovAccess Global

Industry

Biotechnology

Employees

2

CEO

Dwain Morris-Irvin, PhD

Headquarters

Chesterland, OH 44026, US

XSNX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

32%

Return on Assets

-77%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.20K

Shares Outstanding

61.65M

Volume

170

Avg. Volume

691.266

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$2.47M

EBITDA

-$1.03M

Operating Cash Flow

-$624.64K

Capital Expenditure

-$4.00

Free Cash Flow

-$624.64K

Cash & ST Invst.

$21.42K

Total Debt

$2.20M

NovAccess Global Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.20K

N/A

Market Cap/Employee

$2.07K

N/A

Employees

3

N/A

Net Income

-$936.33K

-20.1%

EBITDA

-$435.26K

-558125.6%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$794.00

-98.7%

Total Debt

$2.09M

+9.8%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$2.09M

+9.8%

Return on Assets

-76.62%

N/A

Return on Invested Capital

31.63%

N/A

Free Cash Flow

-$58.87K

+48.0%

Operating Cash Flow

-$58.87K

+48.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARDSAridis Pharmaceuticals, Inc.
$0.00+0.00%
EVLOEvelo Biosciences, Inc.
$0.00-66.67%
TRVNTrevena, Inc.
$0.00-90.99%
HLUNHEALTHeUNIVERSE, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.04-0.02%

Questions About XSNX

What is the current price of NovAccess Global?

NovAccess Global is trading at $0.00 per share.

What is the 52-week range for NovAccess Global?

Over the past 52 weeks, NovAccess Global has traded between $0.00 and $0.05.

How much debt does NovAccess Global have?

As of the most recent reporting period, NovAccess Global reported total debt of $2.22M.

How much cash does NovAccess Global have on hand?

NovAccess Global reported $20.89K in cash and cash equivalents in its most recent financial results.

What is NovAccess Global’s dividend yield?

NovAccess Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.